(Hypertension. 2000;36:1035.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From the Hypertension Unit, Heart Institute (InCor), University of São Paulo Medical School (Brazil).
Correspondence to Fernanda Marciano Consolim-Colombo, MD, PhD, Heart Institute (InCor), Hypertension Unit, Av Dr Eneas de Carvalho Aguiar 44, São Paulo, 05403-000 Brazil. E-mail hipfernanda{at}incor.usp.br
| Abstract |
|---|
|
|
|---|
Key Words: baroreflex heart rate autonomic nervous system cardiovascular diseases baroreceptors
| Introduction |
|---|
|
|
|---|
Chagas disease, or American trypanosomiasis, is caused by the hemoflagellate Trypanosoma cruzi and is an important cause of heart disease in South and Central America. The pathological involvement of the heart in the chronic phase of Chagas disease is characterized by the presence of inflammatory infiltrates, focus of myocarditis, pericarditis, and perigangliitis, associated with focal fibrosis, with a variable intensity.3 Several anatomopathology studies in experimental models and in human beings have shown conspicuous autonomic denervation in Chagas disease. Therefore, Chagas heart disease can be considered a natural model of intrinsic cardiac nervous system denervation.4 Physiological studies and pharmacological tests have demonstrated impairment in the parasympathetic and sympathetic control of the sinus node in chronic Chagas disease. This alteration was observed in different clinical manifestations of Chagas disease, such as the latent form, cardiac involvement with or without heart failure, and digestive "mega" syndromes.5 However, no study was performed on the reflex that originated in receptors localized in the heart that potentially might be involved in the pathological lesions observed in Chagas heart disease. Therefore, the purpose of this study was to determine whether cardiopulmonary baroreflex is compromised in Chagas heart disease by recording the reflex responses of circulation during the unloading of the cardiopulmonary baroreceptors. Accordingly, the systemic hemodynamic as well as the forearm blood flow (FBF) and resistance responses to decreases in venous return obtained with incremental negative pressure applied to the lower body were analyzed in patients with Chagas heart disease without heart failure.
| Methods |
|---|
|
|
|---|
2 cardiac rhythm
disturbances considered to be prevalent in Chagas heart
disease (bradycardia, first-degree or second-degree
atrial-ventricular heart blocks, complete or incomplete
right bundle-branch block, left anterior fascicular block,
ventricular and supraventricular
arrhythmias). The left ventricular ejection
fraction measured by Doppler echocardiography
was >60% in all patients with Chagas disease. Written informed
consent was obtained from all subjects before the study, and the
Medical Ethics Committee of the University of São Paulo, Medical
School, São Paulo, Brazil, approved the study protocol.
Experimental Protocol
On the morning of the experiments, the patients were taken to
the Hemodynamic Laboratory for a central venous
catheterization. A polyethylene catheter (Intracath, 16
gauge/24 in) was inserted percutaneously through an
antecubital vein of the left arm and advanced under fluoroscopic vision
in or near the right atrium. The catheter was kept patent by continuous
drip (2 mL/h) of heparinized saline (2 U/mL). After that, the patients
were brought to the Laboratory of Clinical Investigation
of the Hypertension Unit. The subjects were positioned supine in a
lower-body negative pressure (LBNP) chamber (Bioengineering Department,
Heart Institute, University of São Paulo), with the chamber
enclosing the subjects legs with an airtight seal at the level of the
iliac crests. The research laboratory was noise free, and lights were
dimmed. Room temperature was controlled at 22°C, and the temperature
of the LBNP chamber was constant throughout the study. All subjects
rested for
30 minutes after being monitored and before data
collection. The hemodynamic variables were
continuously registered during a 3-minute baseline period and during
the sequential application of LBNP at -10, -15, and -40 mm Hg.
Each stimulus was applied for 3 minutes, and the stimuli were separated
by a 10-minute interval.
Hemodynamic Measurements
Central venous pressure (CVP), arterial blood
pressure, heart rate, and FBF were recorded
simultaneously on a Gould strip-chart recorder (RS
3800, Gould Inc, Recording Systems Division) and on a computer
(Gateway 2000 4DX2-66V) with a system for data analyses, CODAS
(Computer Operated Data Acquisition Software: AT-CODAS; DATAQ,
Instruments).
The CVP (mm Hg) was determined by connecting the central venous catheter to a Gould P23 D transducer, with zero reference estimated to the subjects midaxillary level in the fourth intercostal space. The arterial blood pressure was measured by a digital photoplethysmograph device capable of providing accurate beat-to-beat systolic and diastolic values (Finapress, Omeda 2300, Monitoring Systems). The heart rate was calculated from the analysis of the peak systolic interval of the arterial pressure curves obtained with Finapress. The FBF (mL/100 mL forearm volume per minute) was measured in the right arm by venous occlusion plethysmography, with a double-stranded mercury-in-Silastic strain gauge designed by Whitney.6 Briefly, the strain gauge was placed 5 cm distal the antecubital crease, and the arm was supported 10 cm above the heart level. The venous occlusion pressure was 35 to 40 mm Hg, and circulation to the hands was arrested by inflating a wrist cuff to the suprasystolic pressure (200 mm Hg) for 1 minute before limb blood flow determination. Each FBF determination comprised 12 separated measurements performed at 10-second intervals (a 3-minute period). The FBF for each LBNP stage and baseline was calculated as the mean of all curves registered during the 3-minute registration period. Forearm vascular resistance (FVR) was calculated as mean arterial pressure/FBF and expressed as resistance units (U).
Statistical Analyses
All data were processed with SAS System software. Fishers
exact test or
2 for categoric variables
were used to compare baseline characteristics. Multiple ANOVA was used
to test for group differences for baseline and continuous
variables. Values of P<0.05 were considered
significant. Results are presented as mean±SEM.
| Results |
|---|
|
|
|---|
|
Reflex Responses
LBNP at -10 and -15 mm Hg
In response to -10 and -15 mm Hg of LBNP, the decrease of
CVP was similar in both groups (-2.4±0.2 versus
-3.4±0.2 mm Hg at -10 LBNP and -3.5±0.3
versus -4.3±0.1 mm Hg at -15 LBNP, respectively for control
and Chagas groups). The systolic, diastolic, and
mean arterial pressure and heart rate did not change
significantly compared with the baseline values in both groups (Table 2). The FBF in the control group showed a
significant decrease that was proportional to the intensity of LBNP
(-13.5±4.9% and -18. 9±4.7%, respectively, at -10 and -15
LBNP). In contrast, in the Chagas group, the FBF did not decrease and
even exhibited a tendency to increase compared with baseline
(3.1±5.9% and 10.8±10.3%, respectively, at -10 and -15 LBNP)
(Figure 1). The FVR increased
significantly in the control group and proportionally to the intensity
of LBNP (22.5±6.9% and 33.6±8.7, respectively, at -10 and -15
LBNP), whereas in the Chagas group, no significant changes were
registered (3.9±5.9% and 0.9±6.7%, respectively, at -10 and -15
LBNP) (Figure 2).
|
|
|
LBNP at -40 mm Hg
Also at this level of LBNP, the CVP decreased similarly in both
groups (-6.0±0.5 versus -6.3±0.1 mm Hg, respectively, to
control and Chagas groups). However, the changes of
arterial blood pressure were different in both groups. The
values presented in Table 2 (mean of 3 minutes of LBNP
application) demonstrated that in the control group the
systolic and mean arterial pressures were similar
to baseline values, but the diastolic blood pressure and
heart rate had a significant increase. Otherwise, the Chagas group
exhibited a significant fall in systolic and mean
arterial pressure despite the fact that heart rate
increased significantly, similar to the control group. The
diastolic blood pressure also did not exhibit the increase
observed in the control group. A separate analysis of the blood
pressure and heart rate responses during the first 30 seconds of
application of -40 mm Hg LBNP (data not shown) demonstrated that
the control group exhibited an initial decrease in systolic
blood pressure (-20 mm Hg) that was totally recovered,
associated with a significant increase in the heart rate (15.1±2.8%).
The Chagas group showed a similar initial fall in systolic
blood pressure (-20 mm Hg), but although the heart rate had a
significant increase (13.6±3.8%), the systolic blood pressure
exhibited only a partial recovery, maintaining a lower level during the
application of LBNP. In contrast to LBNP at -10 and -15 mm Hg,
LBNP at -40 mm Hg produced a significant and similar decrease in
the FBF in both groups (-24.7±6.3% versus -26.8±6.0%,
respectively, for control and Chagas groups) (Figure 1). Also,
the FVR increase was similar in both groups (55.8±11.2% versus
43.4±11.8%, respectively, for control and Chagas groups) (Figure 2).
| Discussion |
|---|
|
|
|---|
In this study, we were not able to determine which part of the cardiopulmonary reflex pathway is compromised. On the basis of clinical and Doppler echocardiography data, the patients with Chagas disease exhibited no heart failure. However, the ECGs of all patients exhibited alterations that are considered prevalent in the cardiac form of Chagas disease and are associated with a certain level of cardiac involvement by the disease.11 We can speculate that the cardiac involvement of Chagas disease (focus of myocarditis and fibrosis, pericarditis, perigangliitis) also enrolls cardiac receptors, their afferent fibers, or both.3 4 It has been reported that patients who undergo heart transplantation, a cardiac-denervated group, have deficient cardiopulmonary reflex control of FVR.12 Therefore, alterations at the level of the receptor/afferent fibers could play an important major role in the depressed cardiopulmonary reflex control presently observed.
We cannot rule out the participation of the central nervous system in the abnormal cardiopulmonary reflex control in Chagas disease. However, the involvement of the central nervous system in Chagas disease is rare and not intense, except in reactivation of T Cruzi infection in immunocompromised patients.13 Moreover, the normal response of FVR at intense levels of LBNP, -40 mm Hg, suggests that the sympathetic efferent fibers responsible for the vascular innervation are not impaired in Chagas disease. It is important to remember that no grossly anatomic lesions were described in the vessels of patients with Chagas disease.5
The hemodynamic responses of -40 mm Hg of LBNP in the control group were similar to those described previously.7 The mean arterial pressure was maintained close to the baseline values, with a small decrease in the systolic blood pressure and a significant increase in diastolic blood pressure associated with a significant increase in the heart rate. Although the Chagas patients showed no clinical symptoms or signs of low cardiac output during intense volume unloading, they exhibited a small but significant decrease in both systolic and mean arterial pressures associated with a blunted increase in the diastolic blood pressure. It is important to note that although the blood pressure behaved differently in both groups, the heart rate increased by the same degree. The behavior of arterial blood pressure of patients with Chagas disease during stress testing and the Valsalva maneuver was not different from the control.5 However, with the use of a passive postural stress test (tilt test), it was possible to demonstrate that patients with Chagas disease had a compromised control of blood pressure, such as a decrease in systolic blood pressure and a blunted increase in diastolic blood pressure.14 15 Regarding the control of heart rate, an impairment in heart rate control in Chagas disease was demonstrated in other functional studies.14 16 17 Besides the anatopathological demonstration of cardiac denervation,4 a recent study that used cardiac scanning with 123I-labeled metaiodobenzylguanidine has identified in vivo regional sympathetic denervation in patients with Chagas disease.18 A similar observation was reported in patients with diabetes associated with the functional autonomic involvement of the disease and with a worst prognosis of the disease.19
The normal response of FVR at -40 mm Hg LBNP in patients with Chagas disease indicates that when both arterial and cardiopulmonary receptors are unloaded, the reflex control of FVR is preserved. Previous studies with patients with cardiac transplantation12 and heart failure20 21 demonstrated a defect on reflex control of FBF and resistance during application of low and high levels of LBNP. In these studies, the reflex modulated by cardiopulmonary receptors was considered compromised, although the arterial baroreceptor reflex might also be simultaneously enrolled. Because the increase in vascular resistance depends on an increase in sympathetic nerve activity,22 23 it appears that the sympathetic innervation of this vascular bed is not compromised in Chagas disease. In fact, a study of patients with heart failure24 demonstrated a defect in the sympathetic nerve activity control when cardiopulmonary receptors were unloaded with LBNP and a normal baroreflex response during hypotension produced by administration of sodium nitroprusside, which indicates a more selective defect of the sympathetic control by the cardiopulmonary reflex. In our study, the incapacity of patients with Chagas disease to maintain normal arterial blood pressure at high levels of LBNP suggests the existence of an overall deficient control of cardiovascular control in Chagas heart disease, which deserves further study. Indeed, during -40 mm Hg LBNP, there is a clear fall in blood pressure in patients with Chagas disease. However, the increase in heart rate and FVR was similar to that in control subjects. The fact that the stimulus to the arterial baroreceptors was greater but the response, that is, tachycardia and increased FVR, was not appropriately increased suggests an impairment of the arterial baroreflex in patients with Chagas disease.
Nevertheless, our findings suggest that the impairment of the cardiopulmonary reflex may be enrolled as a cofactor in the constellation of autonomic nervous alterations associated with Chagas disease and could influence the evolution from the latent form of the disease to different clinical manifestations of Chagas chronic disease and sudden death.5 25 26 27
| Acknowledgments |
|---|
Received April 7, 2000; first decision May 15, 2000; accepted June 16, 2000.
| References |
|---|
|
|
|---|
2. Minisi AJ, Thames MD. Reflexes from ventricular receptors with vagal afferents. In: Zucher IH, Gilmore JP, eds. Reflex Control of Circulation. Boca Raton, Fla: CRC Press; 1991:359405.
3.
Morris SA, Tanowitz HB, Wittner M, Bilezikian JP.
Pathophysiological insights into the
cardiomyopathy of Chagas disease.
Circulation. 1990;82:19001909.
4. Oliveira JS. A natural human model of intrinsic heart nervous system denervation. Am Heart J. 1985;110:10921098.[Medline] [Order article via Infotrieve]
5. Amorim DD, Marin-Neto JA. Functional alterations of the autonomic nervous system in Chagas heart disease. Rev Paul Med. 1995;113:772784.[Medline] [Order article via Infotrieve]
6. Whitney RJ. Measurement of volume changes in human limbs. J Physiol (Lond).. 1953;121:127.
7.
Johnson JM, Rowell LB, Niederberger M, Eisman MM.
Human splanchnic and forearm vasoconstrictor responses to reductions of
right atrial and aortic pressure. Circ Res. 1974;34:515524.
8. Lacolley PJ, Pannier BM, Slama MA, Cuche JL, Hoeks AP, Laurent S, London GM, Safar ME. Carotid arterial hemodynamics after mild degrees of lower-body negative pressure in man. Clin Sci. 1992;83:535540.[Medline] [Order article via Infotrieve]
9.
Pannier B, Slama MA, London GM, Safar ME, Cuche JL.
Carotid arterial hemodynamics in response
to LBNP in normal subjects: methodological aspects. J Appl
Physiol. 1995;79:15461555.
10.
Taylor JA, Halliwill JR, Brown TE, Hayano J, Eckberg
DL. Non-hypotensive hypovolemia reduces ascending dimensions in humans.
J Physiol. 1995;483:289298.
11. Mady C, Nacruth R. Natural history of chronic Chagas heart disease: prognostic factors. Rev Paul Med. 1995;113:791796.[Medline] [Order article via Infotrieve]
12.
Mohanty PK, Thames MD, Arrowood JA, Sowers JR, McNamara
C, Szentpetery S. Impairment of cardiopulmonary baroreflex
after cardiac transplantation in humans. Circulation. 1987;75:914921.
13. Villanueva MS. Trypanosomiasis of the central nervous system. Semin Neurol. 1993;13:209218.[Medline] [Order article via Infotrieve]
14. Marin-Neto JA, Gallo-Junior L, Manço JC, Rassi A, Amorim DS. Postural reflexes in chronic Chagas heart disease: heart rate and arterial pressure responses. Cardiology. 1975;60:343357.[Medline] [Order article via Infotrieve]
15. Palmero HA, Caeiro TF, Josa DJ. Distinctive abnormal responses to tilting test in chronic Chagas disease. Klin Wochenschr. 1980;58:13071311.[Medline] [Order article via Infotrieve]
16. Junqueira Junior LF, Gallo Junior L, Manco JC, Marin-Neto JA, Amorim DS. Subtle cardiac autonomic impairment in Chagas disease detected by baroreflex sensitivity testing. Braz J Med Biol Res. 1985;18:171178.[Medline] [Order article via Infotrieve]
17. Guzzetti S, Iosa D, Pecis M, Bonura L, Prosdocimi M, Malliani A. Impaired heart rate variability in patients with chronic Chagas disease. Am Heart J. 1991;121:17271734.[Medline] [Order article via Infotrieve]
18. Giorgi MC, Hironaka FH, Ianni BM, Mady C, Zanardo EL, Abe R, Soares J Jr, Izaki M, Cerri GG, Meneghetti. Scintigraphic in vivo assessment of cardiac sympathetic innervation and perfusion in chagasic patients with normal and abnormal left ventricular function. J Am Coll Cardiol. 1998;31(suppl 5):337C. Abstract.
19.
Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro
E, Sanford T, Wieland DM, Pfeifer MA, Schwaiger M. Cardiac sympathetic
dysinnervation in diabetes: implications for enhanced
cardiovascular risk. Circulation. 1998;98:961968.
20.
Ferguson DW, Abboud FM, Mark AL. Selective impairment
of baroreflex-mediated vasoconstrictor responses in patients with
ventricular dysfunction. Circulation. 1984;69:451460.
21. Mohanty PK, Arrowood JA, Ellenbogen KA, Thames MD. Neurohumoral and hemodynamic effects of lower body negative pressure in patients with congestive heart failure. Am Heart J. 1989;118:7885.[Medline] [Order article via Infotrieve]
22.
Sundlöf G, Wallin BG. Effect of lower negative
pressure on human muscle nerve sympathetic activity. J
Physiol (Lond). 1978;278:525532.
23.
Oren RM, Schobel HP, Weiss RM, Stanford W, Ferguson DW.
Importance of left atrial baroreceptors in cardiopulmonary
baroreflex of normal humans. J Appl Physiol. 1993;74:26722680.
24. Dibner-Dunlap ME, Smith ML, Kinugawa T, Thames MD. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol. 1996;27:358364.[Abstract]
25. Junqueira Junior LF. Possible role of autonomic heart dysfunction in sudden death associated with Chagas disease. Arq Bras Cardiol. 1991;56:429434.[Medline] [Order article via Infotrieve]
26. Rossi MA, Bestetti RB. The challenge of chagasic cardiomyopathy: the pathologic roles of autonomic abnormalities, autoimmune mechanisms and microvascular changes and therapeutic implications. Cardiology. 1995;86:17.[Medline] [Order article via Infotrieve]
27. Ramos SG, Matturri L, Rossi L, Rossi MA. Lesions of mediastinal paraganglia in chronic Chagas cardiomyopathy: cause of sudden death? Am Heart J. 1996;131:417420.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
F. C. de Carvalho, F. M. Consolim-Colombo, C. A. Pastore, M. C. Rubira, J. C. Meneguetti, E. M. Krieger, and M. Wajngarten Acute reduction of ventricular volume decreases QT interval dispersion in elderly subjects with and without heart failure Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2171 - H2176. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Davila Sympathetic nervous system activation in chagasic patients with congestive heart failure J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1723 - 1724. [Full Text] [PDF] |
||||
![]() |
J. A. S. Barreto-Filho, F. M. Consolim-Colombo, G. M. Guerra-Riccio, R. D. Santos, A. P. Chacra, H. F. Lopes, S. H. Teixeira, T. Martinez, J. E. Krieger, and E. M. Krieger Hypercholesterolemia Blunts Forearm Vasorelaxation and Enhances the Pressor Response During Acute Systemic Hypoxia Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1660 - 1666. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |